In the next 510 years, these will be the major areas of investigational drug studies for GBM: targeted combination therapies, antiangiogenic therapies, immunotherapies, epigenetic therapies, cancer stem cell therapies, and cell migration and invasion therapies
In the next 510 years, these will be the major areas of investigational drug studies for GBM: targeted combination therapies,
Read more